≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

Endpoint Browser

C3_MACROGLOBULINEMIA

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C88.0
  • Cause of death: ICD-9 — 2733A
  • Cancer registry: Topography ICD-O-3 — ANY
  • Cancer registry: Morphology ICD-O-3 — 9761|9671
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

239

4. Check minimum number of events

None

239

5. Include endpoints

None

239

6. Filter based on genotype QC (FinnGen only)

176

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF8

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 176 70 106
Unadjusted period prevalence (%) 0.04 0.02 0.05
Median age at first event (years) 70.12 67.11 72.11

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
184
Matched controls
1840
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
+∞
231.5
170
*
XW000
NOMESCO Finland
Bone marrow biopsy
142.5
201.5
105
17
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
+∞
148.9
122
*
9761/3-C42.0
ICD-O-3
Waldenstrom macroglobulinemia of blood
+∞
135.8
113
*
A04AA01
ATC
ondansetron; systemic, rectal
66.5
113.4
65
15
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
29.5
70.0
50
23
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
129.0
59.2
61
7
9671/3-C42.1
ICD-O-3
Lymphoplasmacytic lymphoma of bone marrow
+∞
53.8
49
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
170.3
49.6
50
*
H02AB02
ATC
dexamethasone; systemic
165.7
48.5
49
*
L03AA02
ATC
filgrastim; parenteral
+∞
46.9
43
*
JN4BD
NOMESCO Finland
Extensive body CT
13.2
44.4
48
48
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
36.7
34
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
11.2
33.4
39
43
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
33.3
31
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
32.2
30
*
JN4AD
NOMESCO Finland
Body CT examination
8.8
31.7
46
67
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.1
31.0
58
112
L03AA13
ATC
pegfilgrastim; parenteral
357.9
30.8
30
*
ZX120
NOMESCO Finland
Intravenous
9.2
29.2
40
54
WW500
NOMESCO Finland
Blood transfusion
27.6
26.5
36
16
1512
Kela drug reimbursment
Ibrutinib
+∞
25.6
24
*
390
Kela drug reimbursment
Ibrutinib
+∞
25.6
24
*
M04AA01
ATC
allopurinol; systemic
5.2
25.4
72
201
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
22.3
21
*
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
22.3
21
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
22.3
21
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.6
21.7
50
115
R50.9
ICD-10 Finland
Fever, unspecified
5.0
20.6
56
148
L01AA02
ATC
chlorambucil; oral
+∞
20.2
19
*
L01EL01
ATC
ibrutinib; oral
+∞
20.2
19
*
J05AB01
ATC
aciclovir; systemic
4.3
19.0
69
227
JN6AD
NOMESCO Finland
CT of torso and neck
41.3
18.1
22
6
D64.9
ICD-10 Finland
Anaemia, unspecified
4.7
17.4
49
132
WZC00
NOMESCO Finland
Treatment plan or consultation
3.8
17.4
79
302
J05AB11
ATC
valaciclovir; oral
4.3
17.0
55
165
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
15.9
15
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
15.9
15
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
14.8
14
*
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
+∞
14.8
14
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
14.8
14
*
B03XA01
ATC
erythropoietin; parenteral
81.4
13.8
15
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.3
13.8
25
45
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
13.7
13
*
130
Kela drug reimbursment
Malignant tumour
+∞
13.7
13
*
N08.1*C88.0
ICD-10 Finland
Glomerular disorders in Waldenström's macroglobulinaemia
+∞
13.7
13
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
13.7
13
*
B03XA02
ATC
darbepoetin alfa; parenteral
28.3
13.7
18
7
B02.9
ICD-10 Finland
Zoster without complication
4.9
13.4
33
79
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
13.1
123
702
1XC02, ,
NOMESCO Finland
75.2
12.8
14
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
9.3
11.7
24
29
L01XE27
ATC
[U] ibrutinib
+∞
11.6
11
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
11.6
11
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
11.6
11
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
11.6
11
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
14.0
11.4
19
15
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.7
10.8
40
129
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
10.5
10
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
10.5
10
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
9.8
78
391
L01AA01
ATC
cyclophosphamide; systemic
58.1
9.8
11
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
105.2
9.5
10
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
+∞
9.5
9
*
115
Kela drug reimbursment
Breast cancer
+∞
9.5
9
*
L57.0
ICD-10 Finland
Actinic keratosis
3.7
9.3
32
98
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
38.8
9.1
11
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
8.9
79
413
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.1
8.8
26
71
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
8.8
55
241
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.5
8.6
83
451
H02AB06
ATC
prednisolone; systemic
2.5
8.5
108
664
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
94.2
8.5
9
*
GD1AD
NOMESCO Finland
Thorax CT examination
4.6
8.4
21
50
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
8.4
56
253
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
8.4
8
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
+∞
8.4
8
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
8.4
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.4
8
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
8.4
8
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.0
8.2
25
70
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
35.0
8.2
10
*
J01MA12
ATC
levofloxacin; systemic
2.8
8.1
50
217
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
8.0
52
232
WX402
NOMESCO Finland
General anaesthesia
2.8
7.8
46
194
D70.82
ICD-10 Finland
Drug-induced neutropenia
47.0
7.8
9
*
Z51.5
ICD-10 Finland
Palliative care
4.8
7.6
18
41
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.4
7.5
102
636
PJA10
NOMESCO Finland
Exploration of lymph nodes
83.3
7.5
8
*
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
83.3
7.5
8
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
83.3
7.5
8
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
7.3
7
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
7.3
7
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
7.3
7
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.3
7.1
30
104
JN3AD
NOMESCO Finland
Abdominal CT examination
3.3
7.1
30
104
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.8
7.1
17
27
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
4.7
7.1
17
39
A02BC02
ATC
pantoprazole; systemic
2.6
7.0
140
1019
JN4CD
NOMESCO Finland
Very extensive body CT
11.6
6.9
12
11
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
17.5
6.8
10
6
D70.89
ICD-10 Finland
Neutropenic splenomegaly
41.6
6.8
8
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.3
6.7
14
18
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
15.0
6.5
10
7
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
+∞
6.3
6
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
6.3
6
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
6.3
6
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
6.3
6
*
L02BG04
ATC
letrozole; oral
+∞
6.3
6
*
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
+∞
6.3
6
*
L01BB05
ATC
fludarabine; systemic
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
WZC30
NOMESCO Finland
Teaching
2.9
6.2
32
125
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
4.2
6.1
17
44
N02AA05
ATC
oxycodone; systemic
2.6
6.0
41
185

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
156
79
124.19
229.20
16.8
1.4
15.22
1.14
g/l
25.85
151
73
120
22
154.94
227.70
2.3
1.4
—
—
—
0
0
125
44
86.48
203.63
8.5
1.2
23.00
1.46
ratio
3.10
81
27
149
112
65.68
181.48
14.2
1.3
—
—
—
0
0
89
15
113.98
167.95
1.6
1.3
—
—
—
0
0
93
61
29.80
115.25
13.4
1.2
16.69
10.27
g/l
4.87
85
51
71
34
33.37
99.49
1.8
1.3
—
—
—
0
0
88
7
237.91
91.87
1.4
1.0
—
—
—
0
0
117
164
17.85
91.23
5.4
2.0
60.58
63.75
e9/l
0.37
87
121
57
21
38.88
86.93
2.0
1.0
—
—
—
0
0
125
214
16.10
83.09
5.8
1.9
1.63
1.69
%
0.26
119
189
82
77
18.41
82.00
2.4
1.6
1.51
1.60
g/l
0.35
73
70
68
63
16.53
67.61
1.4
1.3
—
—
—
0
0
121
259
11.72
64.22
5.2
1.3
1.57
2.97
g/l
3.60
109
142
90
141
11.54
61.57
1.6
1.4
—
—
—
0
0
82
115
12.06
61.07
1.6
1.4
—
—
—
0
0
53
0
+∞
58.51
2.8
0.0
1.98
—
mpas
—
36
0
41
20
26.09
55.56
2.6
2.2
1.33
1.72
g/24h
0.14
30
13
75
110
10.82
53.30
1.5
1.4
—
—
—
0
0
49
6
110.26
46.55
1.1
1.0
—
—
—
0
0
139
498
8.32
40.32
18.0
5.0
—
—
—
0
0
42
6
89.90
38.86
1.6
1.0
—
—
—
0
0
89
223
6.79
37.22
7.0
5.4
1.04
1.02
mmol/l
0.20
84
203
124
431
6.76
36.01
7.4
2.6
336.58
368.78
umol/l
2.67
118
373
161
757
10.01
32.27
17.8
5.1
0.04
0.04
e9/l
0.78
150
644
160
749
9.71
32.18
18.0
5.1
0.67
0.61
e9/l
2.04
149
636
161
764
9.86
31.72
18.0
5.2
1.87
1.80
e9/l
0.38
152
663
162
774
10.14
31.66
18.7
5.2
0.15
0.20
e9/l
3.48
152
661
35
6
71.44
31.37
2.0
2.3
34.67
53.28
%
—
35
6
162
792
9.74
30.29
31.3
5.7
3.48
4.32
e9/l
6.00
150
688
58
116
6.84
29.86
9.5
3.5
0.75
1.04
%
0.51
40
27
54
108
6.66
27.65
10.5
3.6
0.45
0.38
%
0.14
37
24
120
483
5.27
27.11
14.2
3.4
7.41
7.40
ph
1.20
98
334
160
833
8.06
26.03
19.1
6.7
1.22
1.21
mmol/l
1.60
145
729
52
109
6.26
25.22
10.1
3.6
0.03
0.10
%
0.44
33
20
82
277
4.54
22.34
3.0
1.9
31.27
29.40
s
1.34
77
271
26
6
50.11
22.06
3.5
1.5
57.42
199.33
e6/l
—
26
6
105
432
4.33
21.74
3.3
2.2
2.80
2.83
mg/l
0.05
93
369
49
114
5.50
20.97
11.1
3.8
0.00
0.00
%
-0.00
31
19
42
89
5.82
19.85
3.4
1.4
2.85
2.86
ug/l
0.01
33
69
22
6
41.31
18.06
4.3
1.0
42.15
40.22
g/l
—
22
6
55
162
4.42
17.44
3.1
2.3
4.69
7.11
umol/l
1.46
50
146
25
14
20.43
17.02
3.2
1.4
33.16
32.93
pg
0.09
25
14
108
520
3.61
16.44
6.1
2.1
2.36
2.35
mmol/l
0.23
99
454
76
294
3.70
16.26
12.6
4.1
—
—
—
0
0
99
465
3.44
15.42
9.4
4.1
—
—
—
0
0
98
460
3.42
15.23
5.6
2.2
—
—
—
0
0
25
20
14.27
14.90
2.3
1.6
509.28
861.45
mg
0.39
25
20
93
433
3.32
14.48
3.0
1.5
—
—
—
0
0
108
562
3.23
13.71
2.5
1.7
21.51
20.06
nmol/l
0.44
98
468
19
9
23.35
13.65
1.4
1.3
—
—
—
0
0
25
25
11.39
13.48
1.2
1.2
—
—
—
0
0
16
5
34.80
12.80
1.6
1.0
—
—
—
0
0
81
369
3.13
12.74
6.8
3.8
81.95
84.77
%
0.53
76
364
39
114
4.07
12.20
1.6
1.1
—
—
—
0
0
19
17
12.31
10.84
1.5
1.2
—
—
—
0
0
113
668
2.79
10.36
5.7
2.5
—
—
estimate
—
0
0
35
107
3.80
10.20
13.9
3.1
1.24
1.22
mmol/l
1.27
35
89
21
43
5.38
10.06
1.5
1.3
—
—
—
0
0
18
19
10.37
9.51
4.9
1.7
3.00
4.63
e9/l
1.42
18
19
110
661
2.65
9.46
32.9
10.0
0.00
0.00
e9/l
0.49
94
542
27
72
4.22
9.45
1.1
1.5
—
—
—
0
0
126
810
2.76
9.43
3.1
2.2
90.98
93.91
pmol/l
0.29
82
416
22
51
4.76
9.15
2.3
1.9
268.00
218.56
mg/l
0.20
12
16
20
43
5.10
9.06
4.5
2.0
2.12
1.68
mg/l
0.60
20
36
19
25
8.34
8.91
6.3
1.6
52.00
59.96
%
0.96
19
25
68
339
2.60
8.40
1.9
1.7
1104.00
1175.29
nmol/l
0.26
52
262
80
432
2.51
8.34
5.5
2.9
—
0.00
estimate
—
0
5
45
183
2.93
8.21
4.5
2.5
3.43
4.64
e9/l
2.86
34
144
93
543
2.44
8.12
5.7
3.2
12.36
179.32
e6/l
0.76
74
406
83
462
2.45
8.03
5.6
3.0
0.78
0.47
e6/l
0.33
66
329
12
8
15.93
7.83
5.5
2.3
0.52
1.14
e9/l
—
12
8
23
63
4.03
7.74
1.0
1.3
—
—
—
0
0
54
250
2.64
7.66
1.9
1.8
—
—
—
0
0
65
334
2.46
7.39
4.5
2.0
2.55
2.44
mmol/l
5.19
60
295
7
0
+∞
7.34
1.3
0.0
—
—
—
0
0
103
650
2.33
7.29
4.0
3.5
1609.39
1496.59
ng/l
0.10
93
557
96
591
2.31
7.17
7.1
3.9
48.71
135.91
e6/l
1.12
74
412
13
13
10.66
7.16
1.3
1.3
—
—
—
0
0
62
318
2.43
7.02
4.4
2.8
515.96
543.07
mosm/kgh2o
0.54
54
267
56
276
2.48
6.90
4.7
3.0
1.28
1.90
e6/l
0.34
30
129
12
11
11.57
6.90
12.4
4.4
—
—
—
0
0
66
351
2.37
6.88
2.3
1.7
2.50
1.32
mg/l
0.40
56
275
46
209
2.60
6.70
1.2
1.2
—
—
—
0
0
16
26
6.63
6.63
1.6
1.1
—
—
—
0
0
49
233
2.50
6.48
1.3
1.3
1.97
12.54
u/ml
1.38
15
79
118
815
2.25
6.40
4.6
3.9
0.00
0.00
estimate
-0.00
31
159
9
5
18.82
6.33
4.0
2.8
2016.67
2400.00
ml
—
9
5
13
17
8.14
6.24
1.9
1.1
—
—
—
0
0
13
17
8.14
6.24
1.5
1.2
160.00
163.73
au/ml
—
6
6
33
132
2.83
6.12
2.8
4.2
97.26
96.43
ng/l
0.01
27
111
119
837
2.19
6.00
19.6
16.9
1.25
1.33
inr
1.16
104
690
26
92
3.13
5.96
2.0
2.6
—
—
—
0
0
118
834
2.16
5.79
4.6
4.0
0.00
0.03
estimate
0.65
31
149
117
825
2.15
5.77
4.7
3.9
0.00
0.00
estimate
-0.00
31
161
98
648
2.10
5.71
3.4
3.5
6.26
6.22
ph
0.16
46
351
66
376
2.18
5.67
4.4
2.4
3.20
4.87
e6/l
1.15
59
337
13
20
6.91
5.67
1.3
1.0
—
—
—
0
0
13
20
6.91
5.67
1.3
1.0
—
—
—
0
0
13
20
6.91
5.67
1.3
1.0
—
—
—
0
0
13
20
6.91
5.67
1.3
1.0
—
—
—
0
0
14
24
6.22
5.65
1.2
1.1
—
—
—
0
0
12
17
7.47
5.53
1.5
1.1
236.17
194.43
u/ml
—
6
7
27
105
2.84
5.25
7.0
3.3
—
—
—
0
0
5
0
+∞
5.23
1.4
0.0
—
—
—
0
0
39
186
2.39
5.04
1.6
1.8
—
—
—
0
0
80
511
2.00
4.93
3.6
3.3
—
—
—
0
0
80
513
1.99
4.86
3.0
2.2
56.60
68.52
u/l
0.61
73
476
11
17
6.80
4.85
2.5
1.1
—
—
—
0
0
8
7
11.87
4.83
1.3
1.4
—
—
—
0
0
11
18
6.42
4.68
2.1
1.1
—
—
—
0
0
30
131
2.54
4.66
2.1
2.1
0.17
0.20
g/l
1.18
23
118
14
32
4.65
4.54
4.6
3.0
—
—
—
0
0
45
240
2.16
4.45
7.7
7.3
7.42
7.41
ph
0.37
21
150
48
263
2.12
4.43
1.5
1.3
49.18
26.53
iu/ml
0.34
12
77
44
233
2.17
4.42
7.6
7.5
0.95
1.20
mmol/l
0.19
39
197
69
432
1.96
4.41
3.3
3.2
0.00
0.17
—
5
12
39
197
2.24
4.40
2.3
1.5
—
—
—
0
0
13
29
4.74
4.34
5.0
2.8
9.32
10.61
pmol/l
0.12
13
29
33
156
2.36
4.33
2.1
1.9
174.81
135.84
ug/g
0.36
27
119
8
9
9.23
4.32
1.4
1.2
—
—
—
0
0
59
352
2.00
4.31
1.6
1.3
—
—
—
0
0
15
47
3.39
4.16
1.7
1.2
13.43
110.58
e6/l
—
7
38
15
48
3.31
4.03
1.7
1.3
52.63
2453.17
e6/l
—
8
40
30
141
2.35
3.98
1.4
1.2
—
—
—
0
0
27
121
2.44
3.97
5.8
4.6
5.21
5.18
kpa
0.06
27
116
8
12
6.91
3.71
1.3
1.2
—
—
—
0
0
46
265
1.98
3.66
8.2
6.8
105.07
104.36
mmol/l
0.55
46
265
13
36
3.81
3.58
1.8
1.1
—
—
—
0
0
57
362
1.83
3.35
4.7
4.6
138.49
395.11
ng/l
0.85
47
312
65
431
1.79
3.31
15.5
4.1
—
—
—
0
0
8
15
5.52
3.23
1.4
1.1
—
—
—
0
0
7
11
6.56
3.21
1.4
1.3
—
—
—
0
0
8
18
4.60
2.83
2.1
1.1
—
—
—
0
0
11
35
3.28
2.69
2.9
3.0
—
—
—
0
0
29
158
1.99
2.67
3.5
1.7
365.28
381.97
nmol/l
0.18
29
144
25
130
2.07
2.61
2.1
2.0
34.58
32.15
u/l
0.13
19
109
135
1142
1.68
2.50
4.1
3.9
14.87
15.00
pmol/l
0.22
121
1020
29
162
1.94
2.49
10.0
9.0
—
—
—
0
0
61
427
1.64
2.45
4.6
3.4
0.00
0.00
estimate
-0.00
25
121
15
65
2.42
2.38
1.1
1.3
—
—
—
0
0
8
23
3.59
2.30
2.3
3.1
—
—
—
0
0
6
14
4.39
2.17
2.3
1.4
88.68
89.23
%
—
6
14
35
220
1.73
2.08
3.6
3.3
7.38
7.39
ph
0.13
18
132
9
32
2.90
2.03
3.1
1.9
50.22
174.54
u/ml
—
9
24
9
32
2.90
2.03
1.1
1.6
—
—
—
0
0
22
121
1.93
1.99
1.5
1.5
—
—
—
0
0
7
22
3.27
1.90
1.0
1.0
—
—
—
0
0
13
59
2.29
1.89
1.9
1.7
—
—
—
0
0
92
741
1.48
1.88
5.4
4.3
54.43
42.41
ng/l
0.27
74
584
6
17
3.61
1.85
2.5
1.1
—
—
—
0
0
6
17
3.61
1.85
1.3
1.1
—
—
—
0
0
134
1169
1.54
1.82
61.4
19.5
14.52
13.73
%
6.38
134
1153
6
18
3.41
1.76
3.5
1.8
0.22
2.16
mmol/l
—
6
18
6
19
3.23
1.67
1.3
1.1
—
—
—
0
0
10
41
2.52
1.67
1.1
1.5
—
—
—
0
0
42
295
1.55
1.62
1.3
1.3
0.33
1.38
u/ml
—
7
77
76
616
1.40
1.40
4.8
3.9
0.00
0.02
estimate
0.50
29
122
89
749
1.36
1.27
5.2
4.5
2.48
2.05
ug/l
0.45
79
672
6
25
2.45
1.25
1.0
1.1
—
—
—
0
0
5
19
2.68
1.22
1.6
1.4
76.50
77.74
pmol/l
—
5
19
6
26
2.35
1.19
3.8
1.9
11.00
10.23
mmol/l
—
6
26
5
20
2.54
1.16
1.2
1.1
1127.00
580.31
ng/l
—
5
13
5
20
2.54
1.16
1.2
1.1
325.20
274.38
ng/l
—
5
13
151
1395
1.46
1.16
5.3
5.1
1.94
2.00
mu/l
0.25
142
1253
15
88
1.77
1.15
6.3
4.9
—
—
—
0
0
7
30
2.38
1.13
1.1
1.2
—
—
—
0
0
17
105
1.68
1.10
1.3
1.3
—
—
—
0
0
7
32
2.23
1.09
1.0
1.2
—
—
—
0
0
19
122
1.62
1.07
6.1
4.4
—
—
—
0
0
57
462
1.34
1.00
5.3
3.9
0.00
0.02
estimate
0.50
25
143
11
63
1.79
0.92
1.4
1.3
—
—
—
0
0
164
1570
1.41
0.71
61.5
21.7
85.24
84.41
umol/l
0.11
164
1545
163
1559
1.40
0.71
50.7
20.6
139.08
139.77
mmol/l
3.14
163
1523
42
506
0.78
0.69
3.5
3.9
—
—
—
0
0
72
638
1.21
0.59
4.4
4.0
—
—
—
0
0
164
1581
1.34
0.56
71.5
23.8
94.17
91.76
fl
8.34
164
1553
164
1582
1.34
0.55
71.4
23.8
30.92
30.51
pg
2.28
164
1554
164
1582
1.34
0.55
72.7
24.4
36.09
40.37
%
22.46
164
1554
164
1583
1.33
0.53
72.2
24.0
118.84
135.76
g/l
27.11
164
1555
60
671
0.84
0.47
1.9
2.0
1.32
1.30
mmol/l
0.05
47
553
7
48
1.48
0.47
2.7
4.8
—
—
—
0
0
49
429
1.19
0.45
3.4
2.9
0.74
0.78
ug/l
0.16
39
301
10
136
0.72
0.39
1.8
1.4
—
—
—
0
0
6
43
1.41
0.35
1.3
1.2
—
—
—
0
0
155
1508
1.18
0.30
37.1
14.5
—
—
—
0
0
11
85
1.31
0.28
3.4
4.0
1.02
1.02
ratio
0.87
11
79
114
1186
0.90
0.26
61.8
21.0
327.77
332.02
g/l
4.56
114
1178
62
666
0.90
0.26
5.3
4.3
23.74
9.14
mg/mmol
0.89
44
425
35
388
0.88
0.24
4.7
4.1
1.02
1.02
kg/l
0.06
27
252
7
95
0.73
0.23
1.0
1.2
—
—
—
0
0
42
385
1.12
0.21
1.6
1.8
494.44
402.60
pmol/l
1.12
34
316
0
11
0.00
0.21
0.0
1.0
—
263.64
—
0
11
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
17
148
1.16
0.17
4.7
2.7
0.48
0.43
e6/l
0.04
17
142
10
120
0.82
0.17
2.5
2.3
1.25
1.07
%
—
10
120
62
653
0.92
0.16
4.2
3.5
6.75
7.55
mmol/l
0.64
53
542
9
109
0.82
0.13
2.2
2.6
24.74
25.53
mmol/l
—
9
104
151
1486
1.09
0.13
5.3
5.7
5.84
6.14
mmol/l
3.18
136
1340
144
1464
0.92
0.13
5.8
7.6
37.51
40.41
mmol/mol
7.04
134
1358
10
116
0.85
0.12
2.5
2.3
0.54
0.58
%
—
10
116
137
1392
0.94
0.10
4.1
4.9
1.13
1.27
mmol/l
0.91
121
1259
15
135
1.12
0.10
3.8
3.1
—
—
—
0
0
144
1460
0.94
0.10
4.6
5.7
1.38
1.45
mmol/l
1.23
130
1327
63
649
0.96
0.07
4.6
3.6
100.84
57.19
mg/l
0.49
50
430
149
1504
0.95
0.06
5.2
6.8
2.29
2.52
mmol/l
2.93
136
1373
146
1469
0.97
0.02
4.5
5.9
4.10
4.41
mmol/l
2.80
133
1348
13
123
1.06
0.01
2.1
2.5
13.32
16.19
nmol/l
0.80
13
111
0
6
0.00
0.00
0.0
5.3
—
26.52
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.9
—
83.67
—
0
9
6
61
0.98
-0.00
1.8
1.3
—
—
—
0
0
7
73
0.96
-0.00
1.9
1.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
6
63
0.95
-0.00
1.2
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
11.04
—
0
5
0
5
0.00
-0.00
0.0
6.8
—
0.70
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_MACROGLOBULINEMIA – Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).